Shares of Prometheus Biosciences soared 70% in premarket trading on Monday after Merck & Co. announced that it would acquire the company in a $10.8 billion deal. The deal, announced Sunday, gives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results